Personal profile
Research interests
Implementation of new treatment options such as MRI guided radiotherapy for different groups of oncological patients such as renal cancer patients
Improving outcomes for patients with pancreatic cancer
Improving outcomes for patients with renal cell carcinoma
In addition to a special interest in Neuro-Oncology and intracranial radiosurgery, as a radiation oncologist, I have been a core member of the clinical team setting up MR-guided adaptive radiotherapy program at the Amsterdam University medical center since 2015 and have set up the clinical program for stereotactic MR-guided adaptive radiation therapy for prostate-, renal- and pancreatic cancer.
In collaboration with the Dutch Pancreatic Cancer Group, I am in (co-)charge of several multicenter pancreatic cancer studies such as:
The PANCOSAR study - a randomized study in which the value of SABR is studied in patients unfit for chemotherapy and with medically inoperable pancreatic cancer with localized disease.
The ARCADE study - a randomized study in which the added value of SABR to chemotherapy or BSC is studied in patients with an isolated local recurrence of primary resected pancreatic cancer.
The LAPSTAR study - a randomized study in which the added value of ablative SABR to chemotherapy is studied in patients with locally advanced pancreatic cancer.
After implementation gated MRI guided radiotherapy for patients with (recurrent) renal cell carcinoma, participation in and collaboration with the International Radiosurgery Oncology Consortium for Kidney (IROCK consortium) is essential to study the value of SABR as an ablative, non-invasive treatment option for this group of patients worldwide.
Specialisation
Radiation Oncologist
Related documents
Education/Academic qualification
PhD, Clinical and preclinical aspects of monoHER in combination with Doxorubicin, VU University: -
… → 4 Jul 2007
Award Date: 4 Jul 2007
Specialty training Radiation Oncology , VU/VUMC
15 Oct 2006 → 15 Oct 2012
Resident Medical Oncology, VU/VUMC
15 Oct 2001 → 15 Oct 2002
External positions
SBRT focus group
… → 2026
member International Radiosurgery Oncology Consortium for Kidney
… → 2030
Keywords
- RZ Other systems of medicine
- R Medicine (General)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Adaptive skin radiotherapy (ASRT): Clinical outcomes and dosimetric evaluation of a time-efficient approach for online adaptive MRI-guided radiotherapy in thorax
Catucci, F., Smiljanic, L., Preziosi, F., Vellini, L., Quaranta, F., Menna, S., Pilloni, E., Iezzi, M., Re, A., Boschetti, A., Aburas, S., Piras, A., Vuolo, A. L., Flore, C., Mameli, M., Dio, C. D., Bruynzeel, A., Boldrini, L., Leeman, J. E. & Mattiucci, G. C. & 1 others, , 1 Jul 2026, In: Clinical and Translational Radiation Oncology. 59, 101174.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy
Dhar, A., Siva, S., Tan, V. S., Mahadevan, A., Bruynzeel, A., Tang, C., Cury, F., Corkum, M., Ali, M., Zaorsky, N. G., Cheung, P., Hannan, R., Hudes, R., Morgan, S., Lo, S., Murthy, V., Correa, R. J. M. & Swaminath, A., 1 May 2026, In: International Journal of Radiation Oncology Biology Physics. 125, 1, p. 136-145 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Long-Term Outcomes of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Prostate Cancer: Results from a real world large patient cohort
van Vliet, C., Tetar, S. U., Bohoudi, O., Cobussen, P., van Maurik, L. M., Meijnen, P., van Moorselaar, R. J. A., Palacios, M. A., Piet, A. H. M., van Rossum, P. S. N., Versteijne, E., Slotman, B. J. & Bruynzeel, A. M. E., 14 Jan 2026, (E-pub ahead of print) In: International journal of radiation oncology, biology, physics.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
Recurrent hematological toxicity after second-line treatment in patients with glioblastoma: indication of a potential predisposition
Van Hout, L., Van den Elzen, F. E. L., De Jong, Z., Grun, N., Broen, M. P. G., Bartelink, I., Bruynzeel, A. M. E., Lagerwaard, F. J., Buter, J., Vandertop, W. P., Westerman, B. A., Lissenberg—Witte, B. I. & Kouwenhoven, M. C. M., 1 Feb 2026, In: oncologist. 31, 2, oyaf411.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile9 Downloads (Pure) -
Re-irradiation of adrenal metastases using MR-guided adaptive SABR: A feasible and effective approach in a high-risk population
Palacios, M. A., Bruynzeel, A. M. E., van Rossum, P. S. N., Bohoudi, O., Senan, S. & Schneiders, F. L., 1 Jan 2026, In: Clinical and Translational Radiation Oncology. 56, 101056.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile26 Downloads (Pure)